Clinical Trials Logo

Clinical Trial Summary

The clinical study's primary objective is to compare the overall analgesic effect of the Provant Therapy System (test device) to an identical sham device (placebo) in subjects experiencing post-operative pain following first metatarsal bunion surgery. The study hypothesis is that, over the first 72 hours (3 days) after the initial test device treatment, subjects treated with an active test device will show a statistically significant difference (reduction) in pain intensity scores when compared with subjects treated with a sham (placebo) device. Treatment with the test device will continue through the 168 hour (7 day) timepoint. Safety will be followed through 28 days.

Clinical Trial Description


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

NCT number NCT01694199
Study type Interventional
Source Regenesis Biomedical, Inc.
Status Terminated
Phase N/A
Start date September 2012
Completion date December 2012

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03730350 - Perioperative ACT-Based Clinical Hypnosis for Opioid Weaning N/A
Completed NCT03599089 - Study of CA-008 in Bunionectomy Patients Phase 2
Completed NCT02145221 - Effects of Music Therapy on the Recovery of Patients Undergoing Spine Surgery N/A
Terminated NCT03421522 - Intercostobrachial Nerve Sparing to Reduce Post-Surgical Pain N/A
Completed NCT02807428 - Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Phase 2
Completed NCT02523235 - Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Phase 4